Efficacy and safety of a switch to latanoprost 0.005% + timolol maleate 0.5% fixed combination eyedrops from tafluprost 0.0015% monotherapy.
Not Applicable
- Conditions
- glaucoma
- Registration Number
- JPRN-UMIN000017687
- Lead Sponsor
- Department of Ophthalmology, Keio University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
# Angle closure # History of glaucoma surgery # Bronchial asthma
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method intraocuar pressure
- Secondary Outcome Measures
Name Time Method complications